Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance.
about
Antiseptics and disinfectants: activity, action, and resistanceA putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viabilityBinding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia.Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistanceLipopolysaccharide core phosphates are required for viability and intrinsic drug resistance in Pseudomonas aeruginosaCationic antimicrobial peptide resistance in Neisseria meningitidis.Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptidesAnimal antimicrobial peptides: an overview.Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes.Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivoransFosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolatesSphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa.Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria.Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.Phosphorylation of the lipid A region of meningococcal lipopolysaccharide: identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide.Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance.Agents that increase the permeability of the outer membrane.Bacterial Evasion of Host Antimicrobial Peptide DefensesPathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A.The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides.Polymyxins revisited.Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderiaExtreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia.Biocides--resistance, cross-resistance mechanisms and assessment.Biosynthesis and structure of the Burkholderia cenocepacia K56-2 lipopolysaccharide core oligosaccharide: truncation of the core oligosaccharide leads to increased binding and sensitivity to polymyxin BA murine model for infection with Burkholderia cepacia with sustained persistence in the spleen.Regulation of polymyxin resistance and adaptation to low-Mg2+ environments.Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B.Treatment and prevention of Staphylococcus epidermidis experimental biomaterial-associated infection by bactericidal peptide 2.Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia.Construction of a deep-rough mutant of Burkholderia cepacia ATCC 25416 and characterization of its chemical and biological properties.PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance.A two-tier model of polymyxin B resistance in Burkholderia cenocepacia.Characterization of hemolytic and antifungal substance, cepalycin, from Pseudomonas cepacia.
P2860
Q24550729-A1A73291-DBF7-47AD-B22D-BAC7D7293F1BQ24680372-DF8902AE-4729-429A-A455-5D7D787879A4Q24807172-EA180E59-0F79-47D5-A0E6-4413234732B0Q26991811-374D458B-CDD2-4977-BC87-7BEE50671252Q28493092-459D4E49-38BB-4492-9A63-62A04E295DDFQ30857151-520E001A-5F54-4B16-AB4F-E4BB61B7D8B6Q30992994-02667FD4-6529-4F71-9B9C-6873D250036FQ33638713-C0A50FDB-A4A7-4D09-8358-024B7476C959Q34033883-FF02D505-380A-4C27-A84E-C90FFE8AC2B8Q34049989-3396B2CD-527A-407D-B72D-1A9FB7F46346Q34057514-ECCFE77E-964A-45AC-9314-9DB71FC4A98AQ34342508-9A444059-D976-4C8E-9E59-02C61991A9A1Q34631433-667CEED7-2836-44BB-AE76-CCA2809778ABQ34933915-DC59AA19-6272-4508-9489-ED0DA265BAFCQ35006104-2AD1E4E1-CE4D-4037-8502-65BD11A36306Q35122241-5F52B0FC-F317-447B-9C2C-D2D729FE51E0Q35403079-33BFEDDA-EE1F-43DB-AF9F-328A5F9E1CE9Q36720179-2FCFB548-E690-4FBE-98EC-961544ED2058Q36804699-56123304-118B-4C80-9A92-5A21C6E30DF4Q37033480-F2565874-B3D2-434F-9EC3-96BD4FE15C82Q37194242-BDF9CE01-C40C-474C-BD5E-9E6F66E24C30Q37215935-5C8CA1CD-5A4E-4E17-B008-4BDD729FC841Q37910758-0D79CA93-F08B-4172-A664-9AB9242310DEQ38037528-94713F5F-D656-40E5-B730-AA4ED37CEC96Q38065203-FAF36BC5-1B80-4F29-BE6C-C63F47D2B95AQ38353160-3B3FE3D8-68B9-461C-9677-721136DF2ADAQ39511333-40017A54-21FD-4A4A-AEF2-6049D81DB3D3Q39847917-7F9836A6-0C22-4C43-9204-454E2D38FD73Q39863922-BCE0F0D5-35FA-483F-B40D-D117DA1F538CQ40902504-16C77D02-3C36-4A28-9D83-D2F163BB4D5BQ41478684-EE475840-33E8-4856-88CE-58F95E52B1C2Q44213444-620B92DE-4129-414C-B5F2-D5250C121118Q48038471-9D35C8AF-D2E5-4766-9D86-EEC7DBFF52F7Q50913117-C4AFC244-4540-4E9E-A048-1C0FD83EE49AQ54223179-2716CEEC-8A36-4D95-962E-9E2C929770C9
P2860
Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Ionizing groups in lipopolysac ...... tion to antibiotic resistance.
@en
Ionizing groups in lipopolysac ...... tion to antibiotic resistance.
@nl
type
label
Ionizing groups in lipopolysac ...... tion to antibiotic resistance.
@en
Ionizing groups in lipopolysac ...... tion to antibiotic resistance.
@nl
prefLabel
Ionizing groups in lipopolysac ...... tion to antibiotic resistance.
@en
Ionizing groups in lipopolysac ...... tion to antibiotic resistance.
@nl
P2860
P1476
Ionizing groups in lipopolysac ...... tion to antibiotic resistance.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2958.1991.TB00735.X
P407
P577
1991-03-01T00:00:00Z